ARCHIVES

Funding Opportunities: NCI Grant Supplements For Mammalian Models

This article is from The Cancer Letter archive.

Vol. 25 No. 40 | October 22, 1999

Download PDF Visit The Full Archive

Related Articles

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988

Federal Hospitals Should Share Radiotherapy Facilitates: GAO

February 16, 1979

“Dog And Pony Show” At FCRF For NCAB OFF

April 25, 1980

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006